Carta al Director
Algunos comentarios a la carta «Controversia en cuanto al uso del icatibant como profilaxis en el angioedema»
Some comments to the letter «Controversy to use icatibant for prophylaxis in angioedema»
F. Iturri Claveroa,
, A. González Uriartea, G. Tamayo Medela,c, A. Martínez Ruíza,d, P. Manuel Gamboa Setiénb
Autor para correspondencia
a Servicio de Anestesiología y Reanimación, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España
b Servicio de Alergología, Hospital de Basurto, Bilbao, Vizcaya, España
c Departamento de Farmacología, Universidad del País Vasco, Leioa, Vizcaya, España
d Facultad de Medicina y Odontología HUC, Centro doctorado, Departamento de Cirugía, Radiología y Medicina Física, Universidad del País Vasco, Leioa, Vizcaya, España
Leído
504
Vecesse ha leído el artículo
334
Total PDF
170
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 1 | 1 |
| 2025 11 | 0 | 2 | 2 |
| 2025 10 | 0 | 3 | 3 |
| 2025 8 | 0 | 3 | 3 |
| 2025 7 | 0 | 8 | 8 |
| 2025 6 | 0 | 2 | 2 |
| 2025 5 | 0 | 1 | 1 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 1 | 1 |
| 2025 2 | 0 | 3 | 3 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 3 | 3 |
| 2024 11 | 0 | 3 | 3 |
| 2024 10 | 0 | 1 | 1 |
| 2024 9 | 0 | 1 | 1 |
| 2024 8 | 0 | 3 | 3 |
| 2024 7 | 0 | 4 | 4 |
| 2024 6 | 0 | 2 | 2 |
| 2024 5 | 0 | 4 | 4 |
| 2024 4 | 0 | 2 | 2 |
| 2024 3 | 1 | 5 | 6 |
| 2024 2 | 0 | 4 | 4 |
| 2024 1 | 0 | 1 | 1 |
| 2023 12 | 0 | 3 | 3 |
| 2023 11 | 0 | 3 | 3 |
| 2023 10 | 0 | 10 | 10 |
| 2023 9 | 0 | 10 | 10 |
| 2023 8 | 2 | 4 | 6 |
| 2023 7 | 0 | 3 | 3 |
| 2023 5 | 0 | 1 | 1 |
| 2023 4 | 0 | 3 | 3 |
| 2023 2 | 0 | 1 | 1 |
| 2022 1 | 0 | 3 | 3 |
| 2022 12 | 4 | 3 | 7 |
| 2022 10 | 0 | 2 | 2 |
| 2022 9 | 0 | 2 | 2 |
| 2022 6 | 0 | 4 | 4 |
| 2022 5 | 0 | 2 | 2 |
| 2022 3 | 1 | 2 | 3 |
| 2022 2 | 0 | 1 | 1 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 3 | 3 |
| 2021 7 | 0 | 2 | 2 |
| 2021 6 | 0 | 1 | 1 |
| 2021 5 | 1 | 2 | 3 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 3 | 10 | 13 |
| 2021 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 6 | 6 |
| 2020 11 | 0 | 1 | 1 |
| 2020 10 | 0 | 2 | 2 |
| 2020 5 | 0 | 3 | 3 |
| 2020 4 | 0 | 4 | 4 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 6 | 6 |
| 2020 1 | 0 | 4 | 4 |
| 2019 12 | 0 | 2 | 2 |
| 2019 8 | 0 | 5 | 5 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 0 | 17 | 17 |
| 2019 5 | 2 | 12 | 14 |
| 2019 4 | 0 | 1 | 1 |
| 2019 2 | 0 | 3 | 3 |
| 2018 12 | 0 | 3 | 3 |
| 2018 11 | 0 | 3 | 3 |
| 2018 10 | 0 | 6 | 6 |
| 2017 10 | 1 | 0 | 1 |
| 2017 7 | 4 | 1 | 5 |
| 2017 6 | 8 | 2 | 10 |
| 2017 5 | 17 | 4 | 21 |
| 2017 4 | 7 | 5 | 12 |
| 2017 3 | 10 | 34 | 44 |
| 2017 2 | 13 | 5 | 18 |
| 2016 1 | 14 | 3 | 17 |
| 2016 12 | 24 | 5 | 29 |
| 2016 11 | 34 | 10 | 44 |
| 2016 10 | 0 | 3 | 3 |
| 2016 9 | 0 | 2 | 2 |
| 2016 8 | 0 | 2 | 2 |
| 2016 7 | 0 | 1 | 1 |
| 2016 6 | 0 | 2 | 2 |
| 2016 5 | 1 | 4 | 5 |
| 2016 4 | 0 | 3 | 3 |
| 2016 3 | 0 | 2 | 2 |
| 2016 2 | 2 | 5 | 7 |
| 2015 1 | 1 | 2 | 3 |
| 2015 12 | 1 | 3 | 4 |
| 2015 11 | 10 | 6 | 16 |
| 2015 10 | 9 | 7 | 16 |
Mostrar todo
